Literature DB >> 9199982

Clinical characteristics of progressive vitiligo.

S K Hann1, W H Chun, Y K Park.   

Abstract

BACKGROUND: Vitiligo is an acquired hypopigmentary disorder with a progressive clinical course. Various clinical characteristics and their significance in the progression of vitiligo were evaluated.
METHODS: A clinical study was carried out on 400 patients who had visited the Vitiligo Special Clinic of Severance Hospital, Yonsei University College of Medicine. Questionnaires were completed regarding progression, sex, family history, clinical type, onset age, duration of disease, Koebner's phenomenon, leukotrichia, and mucosal involvement, and the results were recorded.
RESULTS: Progression of vitiligo was seen in 355 patients (88.8%); 45 patients (11.2%) did not show progression. No difference in sex, onset age, or leukotrichia was noted between the two groups; however, patients with positive family histories, nonsegmental clinical type, longer duration, Koebner's phenomenon, and mucous membrane involvement showed more progression of vitiligo.
CONCLUSIONS: Clinical characteristics such as family history, clinical type, duration of disease, Koebner's phenomenon, and mucous membrane involvement, may be relevant in predicting the progression or prognosis of vitiligo.

Entities:  

Mesh:

Year:  1997        PMID: 9199982     DOI: 10.1046/j.1365-4362.1997.00162.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  6 in total

1.  Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.

Authors:  K Ezzedine; H W Lim; T Suzuki; I Katayama; I Hamzavi; C C E Lan; B K Goh; T Anbar; C Silva de Castro; A Y Lee; D Parsad; N van Geel; I C Le Poole; N Oiso; L Benzekri; R Spritz; Y Gauthier; S K Hann; M Picardo; A Taieb
Journal:  Pigment Cell Melanoma Res       Date:  2012-05       Impact factor: 4.693

Review 2.  Stability in Vitiligo: Is there a Perfect Way to Predict it?

Authors:  Kanika Sahni; Davinder Parsad
Journal:  J Cutan Aesthet Surg       Date:  2013-04

3.  Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo.

Authors:  Selina K Tour; Kim S Thomas; Dawn-Marie Walker; Paul Leighton; Adrian Sw Yong; Jonathan M Batchelor
Journal:  BMC Dermatol       Date:  2014-06-14

4.  Anti-thyroid peroxidase antibody in vitiligo: a prevalence study.

Authors:  R Dash; A Mohapatra; B S Manjunathswamy
Journal:  J Thyroid Res       Date:  2015-01-11

5.  Vitiligo and the melanocyte reservoir.

Authors:  Rafael Falabella
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

6.  Profile of vitiligo in kumaun region of uttarakhand, India.

Authors:  Saurabh Agarwal; Amit Ojha; Shalini Gupta
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.